•
Jun 30, 2021

REGENXBIO Q2 2021 Earnings Report

Total Revenue
$22M
Previous year: $16.6M
+33.0%
EPS
-$1.36
Previous year: -$0.91
+49.5%
Gross Profit
$12.2M
Previous year: $11.9M
+2.8%
Cash and Equivalents
$257M
Previous year: $94.2M
+172.8%
Free Cash Flow
-$46.8M
Previous year: -$24.8M
+88.9%
Total Assets
$836M
Previous year: $450M
+86.0%

REGENXBIO

REGENXBIO